Emcure, Biological E License Three ICMR Biomedical Technologies For Commercial Use SahiICMR licenses cancer, vaccine technologies to Emcure, Biological E The Economic TimesICMR transfers indigenous cervical cancer drug and vaccine technologies to Emcure and Biological E BusinessLineICMR licenses three indigenous medical technologies to Indian pharma firms for cancer and vaccine solutions Deccan HeraldICMR’s PatentMitra Initiative Marks Major Milestone with Transfer of Three Key Biomedical Innovations to Industry Partners drugscontrol.org
Emcure, Biological E License Three ICMR Biomedical Technologies For Commercial Use SahiICMR licenses cancer, vaccine technologies to Emcure, Biological E The Economic TimesICMR transfers indigenous cervical cancer drug and vaccine technologies to Emcure and Biological E BusinessLineICMR licenses three indigenous medical technologies to Indian pharma firms for cancer and vaccine solutions Deccan HeraldICMR’s PatentMitra Initiative Marks Major Milestone with Transfer of Three Key Biomedical Innovations to Industry Partners drugscontrol.org
